Lee Bora, Lee Sang Wook, Kang Hye Rim, Kim Dae In, Sun Hwa Yeon, Kim Jae Heon
Department of Biostatistics, Clinical Trial Center, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Department of Urology, Soonchunhyang University Bucheon Hospital, Soonchuhyang University Medical College, Bucheon, Korea.
Neurourol Urodyn. 2018 Jan;37(1):426-433. doi: 10.1002/nau.23320. Epub 2017 Jun 13.
This study attempted to investigate the association between lower urinary tract symptoms (LUTS) and cardiovascular disease (CVD) risk using International Prostate Symptom Score (IPSS) and CVD risk scores and to overcome the limitations of previous relevant studies.
A total of 2994 ostensibly healthy males, who participated in a voluntary health check in a health promotion center from January 2010 to December 2014, were reviewed. CVD risk scores were calculated using Framingham risk score and American College of Cardiology (ACC)/American Heart Association (AHA) score. Correlation and multivariate logistic regression analysis to predict the CVD risk severity were performed.
Correlation between total IPSS with CVD risk scores demonstrated significant positive associations, which showed higher correlation with ACC/AHA score than the Framingham score (r = 0.18 vs 0.09, respectively). For ACC/AHA score, the partial correlation after adjustment of body mass index (BMI) showed significant positive correlations between all LUTS parameters and PSA. For the Framingham score, all variables, except IPSS Q2 and IPSS Q6, showed significant positive correlations. After adjustment of BMI, prostate volume and PSA, only the severe LUTS group showed significant relationship with intermediate-high CVD risk severity, as compared with normal LUTS group (OR = 2.97, 95%CI (1.35-6.99)).
Using two validated CVD risk calculators, we observed that LUTS is closely associated with future CVD risk. To predict the intermediate-high CVD risk severity, severe LUTS was a sentinel sign, the presence of which warrants the importance of an earlier screening for CVD.
本研究试图利用国际前列腺症状评分(IPSS)和心血管疾病(CVD)风险评分来调查下尿路症状(LUTS)与心血管疾病风险之间的关联,并克服以往相关研究的局限性。
回顾了2010年1月至2014年12月在一家健康促进中心参加自愿健康检查的2994名表面健康的男性。使用弗雷明汉风险评分和美国心脏病学会(ACC)/美国心脏协会(AHA)评分计算心血管疾病风险评分。进行相关性和多因素逻辑回归分析以预测心血管疾病风险严重程度。
IPSS总分与心血管疾病风险评分之间的相关性显示出显著的正相关,与ACC/AHA评分的相关性高于弗雷明汉评分(分别为r = 0.18和0.09)。对于ACC/AHA评分,调整体重指数(BMI)后的偏相关性显示所有LUTS参数与前列腺特异性抗原(PSA)之间存在显著正相关。对于弗雷明汉评分,除IPSS Q2和IPSS Q6外的所有变量均显示出显著正相关。调整BMI、前列腺体积和PSA后,与正常LUTS组相比,只有严重LUTS组与中高心血管疾病风险严重程度存在显著关系(比值比[OR]=2.97,95%置信区间[CI](1.35 - 6.99))。
使用两种经过验证的心血管疾病风险计算器,我们观察到LUTS与未来心血管疾病风险密切相关。为了预测中高心血管疾病风险严重程度,严重LUTS是一个警示信号,其存在表明早期筛查心血管疾病的重要性。